Filing Details

Accession Number:
0001127602-23-009310
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-03-07 16:50:21
Reporting Period:
2023-03-03
Accepted Time:
2023-03-07 16:50:21
Original Submission Date:
2023-03-06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Bausch Health Companies Inc. BHC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1923756 Seana Carson 400 Somerset Corporate Boulevard
Bridgewater NJ 08807
Evp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Disposition 2023-03-03 780 $9.34 443,730 No 4 S Direct
Common Shares, No Par Value Disposition 2023-03-06 495 $9.17 443,235 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.
  2. This Form 4/A is being filed to correct the transaction code originally used to report this transaction on a Form 4 filed by the Reporting Person on 03/06/23. Due to an inadvertent administrative error, this transaction was originally incorrectly reported using code "F" instead of transaction code "S".